Biodexa Pharmaceticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-06-30 |
|---|---|---|---|---|
Gross Profit | -48 | -1,665 | -3,248 | -2,189 |
EBITDA | -4,675 | -3,945 | -4,927 | -3,248 |
EBIT | -4,724 | -4,016 | -4,976 | -3,384 |
Net Income | -2,562 | -3,806 | -2,421 | -3,308 |
Free Cash Flow | -2,325 | -3,305 | -8,228 | -4,807 |
Cash | 8,518 | 4,035 | 1,669 | 5,055 |
Basic Shares | 225 | 252 | 61 | 2 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $381 | $699 |
Gross Profit | -184 | -5,437 | -3,686 | -4,412 |
EBITDA | -8,083 | -9,082 | -7,161 | -8,261 |
EBIT | -8,268 | -9,199 | -7,444 | -8,435 |
Net Income | -6,244 | -5,729 | -7,079 | -7,656 |
Net Change In Cash | 0 | 0 | 381 | 699 |
Free Cash Flow | -5,396 | -13,035 | -7,089 | -7,110 |
Cash | 8,518 | 1,669 | 5,971 | 2,836 |
Basic Shares | 54 | 61 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$15.06 |
2025-03-31 | -$36.54 |
2022-09-30 | $0 |
2022-06-30 | $0 |
